Product Description: Enibarcimab is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody, could be used for acute heart failure, COVID-19 infections and septic shock research[1].
Applications: COVID-19-anti-virus
Formula: N/A
References: [1]James E, et al. The Immune System and Chronic Heart Failure: Is the Heart in Control? Journal of the American College of Cardiology. 2019. 53(12):1013-1020.